Evidence map›Paper›PMID 41767650›Full record

SynthesisPublic health reviews2026

Machine Learning Used in Communicable Disease Control: A Scoping Review.

Sharon Birdi, Atushi Patel, Roxana Rabet, Navreet Singh, Steve Durant, Tina Vosoughi, Faris Kapra, Mahek Shergill, Elnathan Mesfin, Carolyn Ziegler and 15 more

Abstract readSystematic Review
In one paragraph

Synthesis in Public health reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Sharon BirdiUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Atushi PatelUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Roxana RabetUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Navreet SinghUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Steve DurantUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Tina VosoughiUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Faris KapraUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Mahek ShergillUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Elnathan MesfinUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Carolyn ZieglerLibrary Services, Unity Health Toronto, Toronto, ON, Canada.
Shehzad AliDepartment of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
David BuckeridgeDepartment of Epidemiology, Biostatistics and Occupational Health, School of Population and Global Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.
Marzyeh GhassemiDepartment of Electrical Engineering and Computer Science, School of Engineering, Massachusetts Institute of Technology, Cambridge, MA, United States.
Jennifer GibsonJoint Centre for Bioethics, University of Toronto, Toronto, ON, Canada.
Ava John-BaptisteDepartment of Epidemiology and Biostatistics, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.
Jillian MacklinUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Melissa MccraddenDepartment of Bioethics, The Hospital for Sick Children, Toronto, ON, Canada.
Kwame MckenzieWellesley Institute, Toronto, ON, Canada.
Sharmistha MishraDivision of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, ON, Canada.
Parisa NaraeiDepartment of Computer Science, Toronto Metropolitan University, Toronto, ON, Canada.
Akwasi Owusu-BempahDepartment of Sociology, Faculty of Arts and Science, University of Toronto, Toronto, ON, Canada.
Laura RosellaDivision of Clinical Public Health, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
James ShawDepartment of Physical Therapy, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
Ross UpshurJoint Centre for Bioethics, University of Toronto, Toronto, ON, Canada.
Andrew D PintoUpstream Lab, MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Communicable diseases continue to threaten global health, with COVID-19 as a recent example. Rapid data analysis using machine learning (ML) is crucial for detecting and controlling outbreaks. We aimed to identify how ML approaches have been applied to achieve public health objectives in communicable disease control and to explore algorithmic biases in model design, training, and implementation, and strategies to mitigate these biases. Methods: We searched MEDLINE, Embase, Cochrane Central, Scopus, ACM DL, INSPEC, and Web of Science to identify peer-reviewed studies from 1 January 2000, to 15 July 2022. Included studies applied ML models in population and public health to address ten communicable diseases with high prevalence. Results: 28,378 citations were retrieved, and 209 met our inclusion criteria. ML for communicable diseases has risen since 2020, particularly for SARS-CoV-2 (n = 177), followed by malaria, HIV, and tuberculosis. Eighteen studies (8.61%) considered bias, and only eleven implemented mitigation strategies. Conclusion: A growing number of studies used ML for disease surveillance. Addressing biases in model design should be prioritized in future research to improve reliability and equity in public health outcomes.

Indexed as

artificial intelligencecommunicable diseasesmachine learningpopulation healthpublic healthscoping review

Identifiers

PMID41767650
PMCPMC12945845

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.